When used to patch infarcted heart in a murine model of MI, both the hHVS and c-kit+ cell-seeded hHVS significantly improved cardiac performance, with the latter exerting a more profound effect, thus providing a clinically relevant novel scaffold for cardiac tissue engineering. The gene discussed is KIT; the disease is myocardial infarction.